Financial Performance - The company's revenue for the year ended December 31, 2025, was HKD 27,084,000, an increase of 29.4% compared to HKD 20,841,000 in 2024[4] - Gross profit for the same period was HKD 9,865,000, representing a gross margin of 36.4%, compared to HKD 9,198,000 in 2024[4] - The company reported a loss before tax of HKD 7,197,000, a significant improvement from a loss of HKD 20,367,000 in the previous year, indicating a reduction in losses by 64.7%[4] - Revenue from external customers for the year ended December 31, 2025, totaled HKD 27,084 thousand, an increase from HKD 20,841 thousand in 2024, representing a growth of approximately 30.5%[25] - The group reported a loss before tax of HKD 7,197 thousand for the year ended December 31, 2025, compared to a loss of HKD 20,367 thousand in 2024, indicating a significant improvement in financial performance[25] - The loss attributable to the company's owners for the year ended December 31, 2025, was approximately HKD 6,586,000, compared to a loss of HKD 19,791,000 for the year ended December 31, 2024[46] - The basic and diluted loss per share for the year ended December 31, 2025, was approximately HKD 0.0756[46] Assets and Liabilities - Total assets as of December 31, 2025, amounted to HKD 31,930,000, compared to HKD 27,377,000 in 2024, reflecting an increase of 16.5%[5] - Current liabilities increased to HKD 78,686,000 from HKD 67,215,000, representing a rise of 17.5%[5] - The company's net capital deficiency was HKD 45,926,000, worsening from HKD 38,729,000 in 2024, indicating a decline in financial health[6] - Total liabilities exceeded total assets by HKD 45,926,000 as of December 31, 2025, raising significant doubts about the group's ability to continue as a going concern[18] - The group reported a loss of approximately HKD 7,197,000 for the year ending December 31, 2025, with current liabilities exceeding current assets by HKD 46,756,000[17] Cash Flow and Financing - The board has implemented measures to alleviate cash flow pressure and improve financial conditions, including cash flow forecasts for at least the next twelve months[18] - The company may seek additional financing and other fundraising opportunities as necessary to support its operations[20] - The group plans to continue discussions with lenders to extend settlement terms to alleviate short-term liquidity pressure[20] - The management has implemented measures to improve cash flow and is closely monitoring operating and capital expenditures[86] - The company has taken steps to address its liquidity and financial situation, including cash flow forecasting for at least the next twelve months[84] Share Issuance - The company completed a rights issue on March 13, 2026, issuing 261,273,600 shares at a subscription price of HKD 0.2 per share, raising approximately HKD 49.44 million[20] - The proceeds from the rights issue will be used for debt repayment (approximately HKD 32.27 million), costs related to the Qingmao project (approximately HKD 9.75 million), and general working capital (approximately HKD 7.42 million)[80] Operational Focus - The company continues to focus on providing exhibition and trade-related services, as well as online sales of beauty and luxury products[7] - The company will not pursue further investment in the Hong Kong consumer sector due to weak consumer performance[51] - Revenue from luxury goods sales is projected to increase from approximately HKD 6,950,000 for the year ending December 31, 2024, to about HKD 7,120,000 for the year ending December 31, 2025[52] Audit and Compliance - The board of directors confirmed the accuracy and completeness of the financial information presented in the announcement[3] - The independent auditor's report indicates a loss of approximately HKD 7,197,000 for the year ending December 31, 2025, with current liabilities exceeding current assets by HKD 46,756,000[82] - The independent auditor's report expresses a "disclaimer of opinion" due to significant uncertainties regarding the company's ability to continue as a going concern[81] - The audit committee has reviewed the accounting principles and practices adopted by the group for the fiscal year ending December 31, 2025[89] - The consolidated financial statements for the year ending December 31, 2025, have been reviewed by the audit committee[89] Revenue Breakdown - The revenue from the publishing and advertising business increased from approximately HKD 13,207,000 for the year ended December 31, 2024, to approximately HKD 19,852,000 for the year ended December 31, 2025[48] - The revenue from online sales of beauty and cosmetics decreased from approximately HKD 684,000 for the year ended December 31, 2024, to approximately HKD 112,000 for the year ended December 31, 2025[50] - Revenue from major customers accounted for over 10% of total sales, with Customer A contributing HKD 8,484 thousand in 2025[31] - The group operates primarily in the Guangdong-Hong Kong-Macao Greater Bay Area, with external customer revenue from this region reaching HKD 27,084 thousand in 2025[30] Dividend Policy - The company did not recommend the payment of any final dividend for the year ended December 31, 2025[39] - The company will not declare a final dividend for the year ending December 31, 2025, as it aims to retain sufficient capital for business expansion[76]

Financial Performance - For the fiscal year ending December 31, 2025, the company achieved a revenue of RMB 42,124.8 million, representing a year-on-year decline of 9.2%[13] - The net profit attributable to shareholders for the same period was RMB 585.1 million, reflecting a year-on-year growth of 16.8%[13] - In 2025, the company's revenue reached RMB 42.12 billion, a decrease of 9.8% from RMB 46.38 billion in 2024[19] - The gross profit for 2025 was RMB 3.59 billion, resulting in a gross margin of 8.5%, up from 5.8% in 2024[19] - The annual profit attributable to shareholders was RMB 585.12 million, compared to RMB 501.13 million in 2024, marking a 16.7% increase[19] - Revenue from the largest customer accounted for 28.7% of total revenue, while the top five customers contributed 80.4% of total revenue[152] - The total dividend for 2024 was RMB 228.80 million (including tax), indicating a year-on-year increase of approximately 13.9%[138] Market and Product Development - The company shipped over 150 million smartphones in 2025, maintaining its market leadership despite external challenges such as tariff fluctuations and supply chain disruptions[12] - The smartphone business generated revenue of CNY 28.9347 billion, down 19.9% year-on-year, with total shipments of 152 million units[32] - The tablet business achieved revenue of CNY 4.1526 billion, a year-on-year growth of 12.3%, with shipments exceeding 11 million units[33] - AIoT and other products generated revenue of CNY 7.8689 billion, reflecting a year-on-year increase of 41.2%[34] - The global smartphone shipment is projected to reach 1.26 billion units in 2025, reflecting a year-on-year growth of 1.9%[23] - The wearable device market is expected to see shipments exceed 200 million units in 2025, with a growth rate of 6%[26] - The global AI glasses shipment is forecasted to reach 8.7 million units in 2025, a significant increase of 322% year-on-year[26] Strategic Initiatives - The company has officially launched its System-in-Package (SiP) business, which is expected to become a new growth engine through high integration and reliability solutions[12] - The company has made significant progress in its global expansion strategy, actively entering markets in North America, Europe, and Japan, with successful deliveries of smart glasses and AI PCs to major global clients[12] - The company aims to deepen strategic partnerships with global leading clients to drive innovation in AI technology and smart terminals[12] - The company is focusing on the innovative application of embodied industrial robots in smart factories, with steady progress in related projects[12] - The company is committed to a long-term development strategy focused on customer service, new technology, and product innovation, with a core emphasis on deepening existing business[45] Research and Development - The company has over 5,000 personnel in its R&D and technology teams, enhancing its capabilities in various operating systems and hardware development[21] - The R&D team has grown to over 5,000 personnel across multiple centers, enhancing capabilities in product design, testing, and supply chain management, covering various smart terminal products[39] - The company is actively exploring AI technology applications to enhance R&D efficiency and improve user experience[39] - Research and development expenses grew by 30.5% to RMB 2,715.2 million, primarily due to an increase in employee benefits and technical service fees[71] Manufacturing and Operations - All manufacturing bases have obtained ISO 50001 energy management certification, and all operational sites have achieved ISO 14001 environmental management certification[14] - The company is expanding its manufacturing capabilities in Vietnam and India to meet global delivery demands[21] - The company has set up manufacturing centers in Huizhou and Nanchang in China, and overseas centers in Vietnam and India, to meet global customer demands and diversify its supply chain[40] - The company has achieved significant automation in production processes, with multiple stages such as PCBA inspection and assembly now largely automated, enhancing production efficiency[40] Financial Position and Assets - The total assets of the company as of December 31, 2025, were RMB 26.09 billion, while total liabilities stood at RMB 20.26 billion[19] - The asset-liability ratio as of December 31, 2025, was 72%, a slight decrease from 73% as of December 31, 2024[104] - Total non-current assets increased by 20.1% to RMB 5,025.3 million, while current assets decreased by 5.0% to RMB 21,061.0 million[78] - Cash and cash equivalents decreased to RMB 4.9879 billion as of December 31, 2025, from RMB 5.4615 billion as of December 31, 2024, primarily due to year-end purchases of financial products[92] Governance and Compliance - The company has established a comprehensive ESG governance framework to ensure effective supervision and continuous improvement of sustainability measures[133] - The company is committed to compliance with various laws and regulations, including environmental protection and data protection, to avoid significant penalties and operational disruptions[155] - The board of directors has made all dividend decisions based on the company's established dividend policy, considering operational performance and cash flow[137] Risks and Challenges - The company faces risks related to macroeconomic fluctuations and the cyclical nature of the consumer electronics industry, which may adversely affect its business and financial performance[141] - The company has identified potential adverse impacts from a decline in the ODM market size for smart devices due to macroeconomic fluctuations and increasing technical requirements from brand owners[142] - The company faces risks related to international trade tensions and changes in global trade policies, which may adversely affect operations and supply chain arrangements[155] Shareholder and Incentive Plans - The company has two active share incentive plans, with a potential issuance of 5,235,000 A-shares under the restricted share plan, equating to 1.13% of the weighted average number of shares issued during the reporting period[164][166] - The employee stock ownership plan aims to enhance the company's long-term incentive mechanism and attract and retain talent[181] - The total number of restricted shares granted under the employee stock ownership plan (ESOP) is 6,270,000 shares, accounting for approximately 1.22% of the company's total issued share capital as of the report date[190]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 佈 全部或任何部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責 任。 TALENT PROPERTY GROUP LIMITED 新天地產集團有限公司 * （於百慕達註冊成立之有限公司） （股份代號：760） 二零二五年全年業績公佈 主席報告書 本 人 謹 代 表 新 天 地 產 集 團 有 限 公 司（「本公司」）董 事 會，提 呈 本 公 司 及 其 附 屬 公 司（「本集團」）截 至 二 零 二 五 年 十 二 月 三 十 一 日 止 年 度 的 經 審 核 綜 合 業 績。 財務業績 二零二五年，本集團錄得綜合收益及毛利分別約為人民幣241.8百 萬 元（二 零 二 四 年：人 民 幣284.6百 萬 元）及 人 民 幣8.9百 萬 元（二 零 二 四 年：人 民 幣54.8百 萬 元）。 本 年 度 收 益 主 要 來 源 於《新 天 半 山》B區 別 墅，以 及《徐 州 智 慧 產 業 小 鎮》尾 貨 單 ...

截至二零二五年十二月三十一日止年度 年度業績公告 太平洋網絡有限公司（「本公司」）董事會（「董事會」）宣佈本公司及其附屬公司（統稱為「本 集團」）截至二零二五年十二月三十一日止年度的經審核綜合業績，連同截至二零二四年 十二月三十一日止年度的比較數字如下： – 1 – 綜合收益表 | | | 截至十二月三十一日 | | | --- | --- | --- | --- | | | | 止年度 | | | | | 二零二五年 | 二零二四年 | | | 附註 | 人民幣千元 | 人民幣千元 | | 收入 | 3 | 646,967 | 635,039 | | 收入成本 | 4 | (433,716) | (367,732) | | 毛利 | | 213,251 | 267,307 | | 銷售與市場推廣開支 | 4 | (112,752) | (123,225) | | 行政開支 | 4 | (52,249) | (52,033) | | 產品開發開支 | 4 | (38,823) | (36,666) | | 金融資產減值虧損淨額 | 11(b) | (4,034) | (20,249) | | 其他收入 | 5 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不對因本公告全部或任何部份內容而產生或因倚賴該等內容而引致的 任 何 損 失 承 擔 任 何 責 任。 2025年年度業績公告 概 要 本公司於2025年12月31日的財務狀況及2025年 的 經 營 結 果 如 下： – 1 – ‧ 營業收入為4,553.80億元，較2024年 的5,520.25億元減少966.45億 元（降 幅17.51%）。 ‧ 利潤總額為50.09億 元，較2024年 的92.55億元減少42.46億 元(降 幅 45.87%)。 ‧ 淨利潤為25.22億 元， 較2024年 的79.04億元減少53.82億 元（ 降 幅 68.09%）。 ‧ 歸屬上市公司股東淨利潤為13.22億 元，較2024年 的67.46億元減少 54.24億 元（降 幅80.41%）。 ‧ 基本每股收益為0.002元，2024年的基本每股收益為0.24元。 ‧ 資產總額於2025年12月31日 為8,394.89億 元，較2024年12 ...

Financial Performance - Total revenue for the year ended December 31, 2025, reached approximately RMB 2,027.3 million, representing a year-on-year increase of 93.7% compared to RMB 1,046.4 million in 2024[4] - Gross profit for the same period was approximately RMB 178.0 million, up 43.1% from RMB 124.4 million in 2024[4] - Net profit for the year was approximately RMB 24.7 million, reflecting a year-on-year growth of 79.3% from RMB 13.8 million in 2024[4] - Operating profit increased to RMB 36,883 thousand in 2025 from RMB 21,939 thousand in 2024, indicating a growth of approximately 67.9%[66] - Basic and diluted earnings per share for 2025 were RMB 0.19, up from RMB 0.11 in 2024, showing a growth of 72.7%[66] Revenue Breakdown - Revenue from the task and marketing personnel matching service reached approximately RMB 1,120.2 million, a substantial increase of 209.3% compared to RMB 362.2 million in 2024[15] - Revenue from customized marketing solutions was approximately RMB 868.7 million, up 35.3% from RMB 642.1 million in 2024[15] - Revenue from marketing personnel dispatch services amounted to approximately RMB 31.4 million, reflecting a growth of 20.3% from RMB 26.1 million in 2024[15] - Revenue from SaaS+ subscription and other services declined to approximately RMB 7.0 million, a decrease of 56.0% compared to RMB 15.9 million in 2024[13] Customer Growth - The number of paying customers increased to 1,286, a significant rise of 111.5% from 608 in 2024[6] Cost and Expenses - Total costs amounted to approximately RMB 1.8492 billion for the year ending December 31, 2025, an increase of approximately RMB 927.2 million or 100.6% from 2024[20] - Administrative expenses rose by approximately 22.2% to about RMB 975 million, driven by the rapid growth of the task and marketing personnel matching service[23] - The gross margin decreased to approximately 8.8% for 2025, down from 11.9% in 2024, primarily due to increased competition and strategic sacrifices during the company's expansion phase[22] Financial Position - The current ratio improved to 3.0 from 2.5 in the previous year, indicating better short-term financial stability[5] - Cash and cash equivalents decreased by approximately 23.9% to about RMB 1.214 billion, mainly due to the use of funds from the company's initial public offering[32] - Current liabilities decreased to RMB 232,369 thousand in 2025 from RMB 319,819 thousand in 2024, indicating improved financial health[68] - The total assets as of December 31, 2025, were RMB 714,315 thousand, down from RMB 800,708 thousand in 2024, reflecting a strategic focus on asset management[67] Strategic Focus and Future Plans - The company is focusing on AI-driven solutions to enhance operational efficiency and market presence, particularly in the retail sector[7] - The group completed a fundamental transformation into an AI-focused company in the retail sector over the past year[42] - In 2026, the group will officially launch the FluxMens large model and the Fulai intelligent agent family, marking its transformation into an AI company[43] - The group aims to enhance the FluxMens model and Fulai agents to improve data richness and algorithm optimization for complex business scenarios[44] - The group plans to expand into overseas markets including Vietnam, Indonesia, Australia, Japan, South Korea, and the UK starting in 2026[46] - The group will focus on integrating AI into its entire business chain, emphasizing sales and marketing[48] - The group is committed to strengthening its AI core technology capabilities through strategic investments and partnerships[49] - The group will establish academic and research partnerships to build a robust talent system for AI development[47] Compliance and Governance - The board of directors has confirmed compliance with the standards for securities trading during the reporting period[53] - The company has established an audit committee consisting of three independent non-executive directors to oversee financial data and risk management[54] - The audit committee confirmed compliance with applicable accounting principles and standards for the fiscal year ending December 31, 2025, with an independent auditor's report noting a reservation[55] - The company has complied with all relevant laws and regulations that significantly impact its operations during the reporting period[64] Shareholder Returns - The company repurchased a total of 2,602,600 shares, representing approximately 2.15% of the total issued shares, at an average price of HKD 11.49[58] - No final dividend will be declared for the fiscal year ending December 31, 2025, as the company aims to retain cash for operational activities and business development[61] - The company did not declare any special or final dividends for the years ended December 31, 2025, and 2024[87] Trade Receivables and Payables - Trade receivables as of December 31, 2025, amounted to RMB 317,961,000, a decrease from RMB 331,229,000 in 2024, reflecting a decline of approximately 4.3%[88] - The net trade receivables after impairment provisions were RMB 316,528,000 in 2025, down from RMB 329,443,000 in 2024, indicating a reduction of about 3.9%[88] - The aging analysis of trade receivables shows that amounts overdue by 1 to 60 days increased significantly to RMB 311,633,000 in 2025 from RMB 218,551,000 in 2024, representing a growth of approximately 42.5%[88] - Trade payables as of December 31, 2025, were RMB 30,860,000, a significant decrease from RMB 51,513,000 in 2024, reflecting a decline of approximately 40.2%[91] - Other payables decreased to RMB 95,099,000 in 2025 from RMB 124,616,000 in 2024, indicating a reduction of about 23.8%[91] Investments - The company invested a total of HKD 40,000,000 (approximately RMB 36,249,000) in two private offshore funds with guaranteed returns of 5.15% and 5.10%[90][94] - The company redeemed these funds in March 2024, recovering a total of HKD 40,330,000 (approximately RMB 36,595,000), which includes the principal and returns[90][94]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公布的內容概不負責，對其準確性或 完整性亦不發表任何聲明，並明確表示，概不對因本公布全部或任何部份內容而產生或因倚賴該 等內容而引致的任何損失承擔任何責任。 CHINESE PEOPLE HOLDINGS COMPANY LIMITED ύ!҇!!ި!Ԗ!ज़!Ϧ!љ ȐܭԭኀၲຏнԋҥϐԖज़ೢҺϦљȑ ȐިҽжဦǺ792ȑ! 截至2025年12月31日止年度全年業績公布 財務摘要 本年度本集團收入約人民幣22.86億元（2024年：人民幣26.35億元）。 本年度虧損約人民幣143百萬元（2024年：溢利人民幣59百萬元）。 本年度每股虧損為人民幣1.83分（2024年：每股盈利人民幣0.17分）。 於本年度我們不建議派付末期股息（2024年：無）。 中民控股有限公司（「本公司」）董事（「董事」）會（「董事會」）公布本公司及其附屬公司（統稱「本集 團」）截至2025年12月31日止年度（「本年度」）之經審核綜合業績，連同截至2024年之比較數字如下： – 1 – 綜合損益及其他全面收益報表 截至2025年12月31日止年度 – 2 – | | | 202 ...

Financial Performance - The group recorded revenue of approximately RMB 343.2 million, an increase of about RMB 87.0 million or approximately 34.0% compared to the previous year[4] - The loss for the year was approximately RMB 24.2 million, a decrease from RMB 30.1 million in the previous year, primarily due to increased revenue from transportation services by approximately RMB 96.2 million[4] - Basic loss per share for the year was approximately RMB 4.19, compared to RMB 17.87 in the previous year[4] - The total operating loss for the year was approximately RMB 23.5 million, compared to RMB 26.2 million in the previous year[6] - The group’s other income, gains, and losses net amount decreased by approximately RMB 10.3 million[4] - The group reported a significant increase in goodwill and intangible assets from RMB 2,158 thousand in 2024 to RMB 3,648 thousand in 2025, an increase of approximately 69%[8] - The company reported a total loss before income tax of RMB 30,142 thousand, primarily driven by unallocated corporate expenses of RMB 35,328 thousand[24] - The group achieved a strong revenue growth of approximately 34.0% year-on-year, reaching about RMB 343.2 million, driven by the recovery of domestic logistics demand in mainland China and strategic resource reallocation in Shanghai and Hangzhou logistics operations[79] Dividends and Shareholder Returns - The group did not recommend the payment of a final dividend for the year, consistent with the previous year[3] - The company does not recommend the payment of any dividends for the fiscal year ending December 31, 2025[58] - The board does not recommend the payment of a final dividend for the year ending December 31, 2025[132] Revenue Breakdown - Total revenue for 2025 was RMB 208,986 thousand, up from RMB 171,105 thousand in 2024, reflecting a growth of about 22%[8] - Revenue from transportation services rose by approximately 55.4% to about RMB 269.9 million, primarily due to additional income from two new subsidiaries established in Hangzhou[90] - Revenue from warehousing services decreased by approximately 46.7% to about RMB 12.8 million, mainly due to the expiration of a warehouse lease in Guangdong[91] - Revenue from in-house logistics services slightly decreased by about 3.3% to approximately RMB 54.9 million[92] - Revenue from sales of traditional Chinese medicine, goat milk powder, and other products amounted to approximately RMB 4.2 million, reflecting the company's strategy to diversify into the health sector[94] Assets and Liabilities - Non-current assets decreased from RMB 85,722 thousand in 2024 to RMB 24,437 thousand in 2025, a decline of approximately 71%[8] - Current liabilities decreased significantly from RMB 110,713 thousand in 2024 to RMB 32,078 thousand in 2025, a reduction of about 71%[10] - The company's total assets decreased from RMB 256,827 thousand in 2024 to RMB 233,423 thousand in 2025, a decline of approximately 9%[10] - The company’s total liabilities decreased from RMB 123,409 thousand in 2024 to RMB 33,327 thousand in 2025, a reduction of about 73%[10] - As of December 31, 2025, the group had net current assets of approximately RMB 176.9 million and cash and cash equivalents of approximately RMB 90.7 million, compared to RMB 60.4 million and RMB 49.7 million respectively in 2024[103] Cost Management - Employee benefit expenses decreased by approximately RMB 11.9 million, while packaging expenses increased by approximately RMB 87.3 million[4] - Employee welfare expenses decreased by approximately 16.6% to about RMB 60.0 million, attributed to the introduction of smart technology and strategic use of outsourced labor[80] - Financing costs decreased sharply to approximately RMB 0.6 million from about RMB 4.0 million last year, mainly due to reduced bank loans and interest expenses after the sale of a subsidiary[100] - Other expenses decreased from approximately RMB 36.3 million in the previous year to about RMB 31.6 million this year, mainly due to increased outsourcing labor costs offset by reductions in hospitality, fleet operating expenses, and legal and professional fees[101] Strategic Developments - The company is primarily engaged in providing transportation, warehousing, in-house logistics, and customized services, along with the sale of Chinese medicine, milk powder, and other products[12] - The group is making significant progress on the Traditional Chinese Medicine logistics industrial park project in Fuzhou, Jiangxi Province, with construction expected to be completed by the end of 2027[81] - The group plans to deepen cooperation within the Traditional Chinese Medicine industry and explore value-added services such as quality traceability and inventory financing[85] - The group aims to implement a shared logistics model to address changing customer demands and enhance operational efficiency without significantly increasing rental space[84] Financial Reporting and Compliance - The consolidated financial statements for the year ending December 31, 2025, will adopt the same accounting policies and methods as those used for the year ending December 31, 2024, with certain amendments as noted[12] - The company has applied the revised Hong Kong Financial Reporting Standards effective from January 1, 2025, which did not have a significant impact on the consolidated financial position and performance[15] - The group’s consolidated financial statements for the year ending December 31, 2025, have been audited and found consistent with the reported amounts[137] - The audit committee has reviewed the consolidated financial statements and confirmed compliance with applicable accounting standards[138] Workforce and Employment - The company employed 524 full-time employees as of December 31, 2025, down from 640 in 2024, indicating a reduction in workforce[125] Future Outlook - The logistics and warehousing industry in China is expected to continue its structural optimization and high-quality development trajectory in 2025[78] - The group anticipates that logistics spending in the Traditional Chinese Medicine sector will reach approximately RMB 11.07 billion by 2026, providing a favorable market backdrop for expansion strategies[85]

Financial Performance - For the year ending December 31, 2025, the group's revenue was approximately RMB 43,229,100,000, an increase of about 12.9% compared to the previous year[3] - The gross profit for the same period was approximately RMB 8,515,900,000, reflecting a growth of about 21.6%, with a gross margin of approximately 19.7%, up by 1.4 percentage points year-on-year[3] - The profit attributable to shareholders for the year was approximately RMB 4,639,100,000, representing a significant increase of about 71.9% compared to the previous year[3] - The total comprehensive income for the year was RMB 4,845,390,000, compared to RMB 2,708,666,000 in the previous year[6] - Basic earnings per share for the year were RMB 426.55, up from RMB 248.16 in the previous year[6] - The company's net profit was approximately RMB 4.81 billion, reflecting a substantial increase of about 73.1%, with a net profit margin of approximately 11.1%[84] - The pre-tax profit for the year 2025 was RMB 5,415,953,000, an increase from RMB 3,143,534,000 in 2024, reflecting a growth of approximately 72.3%[32] - The total income tax expense for the year 2025 was RMB 608,963,000, up from RMB 366,510,000 in 2024, indicating a year-over-year increase of about 66.1%[32] Dividends and Shareholder Returns - The board proposed a final dividend of HKD 1.206 per share, equivalent to approximately RMB 1.059 per share[3] - The company plans to distribute a final dividend of HKD 120.60 per share for the year ending December 31, 2025, totaling approximately HKD 1,320,335,000, compared to HKD 531,562,000 for the previous year[33] - The board proposed a final dividend of HKD 0.1206 per share, representing a payout ratio of 25.0% of the profit attributable to shareholders, an increase from 20.0% compared to the previous year[86] Research and Development - Research and development expenses for the year amounted to RMB 3,258,580,000, an increase from RMB 2,924,111,000 in the previous year[5] - Research and development expenses for the year were approximately RMB 3.26 billion, an increase of about 11.4%, reflecting increased investment in mobile, automotive, XR, and IoT-related businesses[81] Revenue by Product Segment - Mobile products generated revenue of RMB 27,324,044, up 8.6% from RMB 25,155,480 in the previous year[20] - Automotive products revenue increased by 21.3% to RMB 7,327,752 from RMB 6,039,062[20] - XR products revenue decreased by 7.1% to RMB 2,393,466 compared to RMB 2,577,280 in 2024[20] - Other products saw a significant increase in revenue, rising by 36.7% to RMB 6,183,864 from RMB 4,522,669[20] Assets and Liabilities - Current assets increased to RMB 42,343,463,000 from RMB 37,470,039,000 year-on-year[7] - Total liabilities increased to RMB 27,044,282,000 from RMB 22,397,563,000 year-on-year[8] - The net asset value of the company rose to RMB 29,764,326,000 from RMB 25,292,948,000 year-on-year[8] - The group's total assets as of December 31, 2025, were approximately RMB 59,214.8 million, representing a 10.0% increase compared to RMB 53,947.5 million as of December 31, 2024[88] Cash Flow and Financing - For the year ended December 31, 2025, the net cash generated from operating activities was approximately RMB 6,079.5 million, up from RMB 3,455.3 million in the previous year, reflecting a significant increase of 76.9%[87][90] - The net cash used in investing activities for the year was approximately RMB 999.4 million, significantly lower than RMB 10,436.8 million in the previous year, indicating a reduction in investment outflows[87][91] - The net cash used in financing activities was approximately RMB 2,093.5 million, with cash outflows primarily for repayment of bank borrowings amounting to RMB 7,989.6 million[92] Employee Compensation - The company’s total employee compensation expenses for 2025 amounted to RMB 5,592,644,000, an increase from RMB 5,115,765,000 in 2024[33] - The group employs 34,393 full-time employees and offers competitive compensation and benefits to attract and retain talent[125] Financial Instruments and Investments - The total amount of non-listed financial products decreased to RMB 11,407,427,000 in 2025 from RMB 13,873,739,000 in 2024, a decline of about 17.8%[39] - The fair value of equity investments classified as other comprehensive income increased to RMB 127,041,000 in 2025 from RMB 63,294,000 in 2024, reflecting a growth of approximately 100.5%[37] - Investment income from non-listed financial products measured at fair value through profit or loss amounted to approximately RMB 328,500,000 for the year ended December 31, 2025, compared to RMB 314,100,000 for the previous year[115] Corporate Governance and Compliance - The company has complied with all mandatory disclosure requirements of the corporate governance code as of December 31, 2025[128] - The company has appointed Ms. Cheng Yunfeng as an independent non-executive director effective April 1, 2026[135] - The company has adopted an updated shareholder communication policy to enhance effective communication with shareholders, which will be formally evaluated annually until December 31, 2025[138] Risk Management - The group has implemented measures to reduce foreign exchange risk related to international sales and purchases, primarily denominated in USD[120] - The group has established a dedicated team to manage credit risk associated with trade receivables, significantly reducing overall credit risk exposure[121]

Financial Performance - Revenue for the year ended December 31, 2025, was RMB 1,292.9 million, a decrease of 4.1% compared to RMB 1,348.4 million for the year ended December 31, 2024[3] - Net profit for the year ended December 31, 2025, was RMB 24.1 million, down 33.8% from RMB 36.5 million for the year ended December 31, 2024[5] - Operating profit for the year ended December 31, 2025, was RMB 22.5 million, compared to RMB 27.8 million for the year ended December 31, 2024[7] - The company reported a total comprehensive income of RMB 15.3 million for the year ended December 31, 2025, down from RMB 29.4 million for the year ended December 31, 2024[8] - Basic and diluted earnings per share for the year ended December 31, 2025, were RMB 0.15, compared to RMB 0.23 for the year ended December 31, 2024[8] Assets and Liabilities - Total assets as of December 31, 2025, amounted to RMB 1,055.4 million, down from RMB 1,189.9 million as of December 31, 2024[9] - Current assets as of December 31, 2025, were RMB 947.7 million, compared to RMB 1,086.6 million as of December 31, 2024[9] - Total liabilities for 2025 amount to RMB 396,303,000, while for 2024, it was RMB 469,480,000, indicating a decrease of approximately 15.6%[11] - Current liabilities for 2025 are RMB 382,685,000, compared to RMB 440,902,000 in 2024, reflecting a reduction of about 13.2%[11] - Non-current liabilities total RMB 13,618,000 for 2025, down from RMB 28,578,000 in 2024, showing a decline of approximately 52.4%[11] Revenue Breakdown - B2B sales contributed RMB 656,100 thousand in 2025, up from RMB 649,007 thousand in 2024, while B2C sales decreased to RMB 633,150 thousand from RMB 687,817 thousand[22] - Health products revenue grew significantly by 67.2% year-on-year, reaching RMB 241.8 million, accounting for 18.7% of total revenue[57] - The revenue from adult personal care products decreased by 14.0% to RMB 764.7 million, primarily due to the termination of a strategic partnership with a personal care brand[57] - Revenue from cross-border e-commerce increased by 41.0% to RMB 240.2 million, reflecting a growing market segment[59] Dividends - The board proposed a final dividend of HKD 0.25 per share for the year ended December 31, 2025[6] - The proposed final dividend for the year ended December 31, 2025, is HKD 0.25 per share, totaling HKD 41.5 million (approximately RMB 36.5 million), down from HKD 82.9 million (approximately RMB 75.9 million) in 2024[51] - The company will not declare an interim dividend for the six months ended June 30, 2025, compared to an interim dividend of HKD 0.25 per share for the same period in 2024[50] Corporate Governance - The board of directors consists of three executive directors, one non-executive director, and three independent non-executive directors, ensuring a balanced governance structure[95] - The audit committee, comprising three independent non-executive directors, is responsible for reviewing the company's financial reporting system and internal controls[100] - The company has adopted the corporate governance code and is committed to maintaining high standards of corporate governance[93] Strategic Focus - The company plans to strategically invest in the health sector, focusing on acquiring external quality brands and enhancing its own brand matrix[90] - The company aims to optimize existing core businesses, innovate products and services, and strengthen digital capabilities to drive high-quality growth[90] - The company is actively optimizing its brand matrix and focusing on high-growth potential business areas to mitigate low-price competition risks[54] Cash Flow and Financing - The net cash used in operating activities was RMB 93.8 million, a significant decline from the previous year, primarily due to increased inventory costs related to brand expansion and extended reimbursement periods for promotional expenses[71] - The net cash generated from investing activities was RMB 14.8 million, mainly from receiving dividends of RMB 15.6 million from joint ventures[71] - The net cash used in financing activities was RMB 53.7 million, primarily due to dividend payments of RMB 75.6 million to shareholders, offset by cash obtained from new borrowings of RMB 21.9 million[72] Market Environment - The macro environment shows a moderate recovery in consumer markets, which the company plans to leverage for sustainable development in 2026[88]